Previous close | 20.11 |
Open | 19.95 |
Bid | 19.52 x 1000 |
Ask | 19.60 x 900 |
Day's range | 19.28 - 20.64 |
52-week range | 17.01 - 78.92 |
Volume | |
Avg. volume | 339,190 |
Market cap | 516.815M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.04 |
Earnings date | 08 Aug 2022 - 12 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 48.29 |
FRIENDSWOOD, Texas, May 24, 2022--Castle announced new data showing that its TissueCypher® test outperformed standard of care in predicting progression in Barrett’s esophagus patients.
NEW YORK & FRIENDSWOOD, Texas, May 20, 2022--Research to Prevent Blindness and Castle are partnering to increase opportunities for medical students to gain research experiences in ocular cancer.
FRIENDSWOOD, Texas, May 19, 2022--New data presented at ACMS confirms independent risk-stratification performance of Castle's DecisionDx®-SCC test.